Skip to main content
. 2024 Jul 31;103(4):e209700. doi: 10.1212/WNL.0000000000209700

Table 2.

Baseline Characteristics of Male Rotterdam Study Participants, Including Individuals With and Without Migraine

Male participants All (n = 3,085) With (a history of) migraine (n = 201) Without (a history of) migraine (n = 2,884)
Aura (%) 37 (1.2) 37 (18.4)
Age (y) 66.2 [56.2−74.5] 61.4 [55.8−72.5] 66.5 [56.2−74.6]
Education level (%)
 Primary education 237 (7.7) 20 (10.0) 217 (7.5)
 Lower/intermediate general education or lower vocational education 809 (26.2) 58 (28.9) 751 (26.0)
 Intermediate vocational education or higher general education 1,125 (36.5) 60 (29.9) 1,065 (36.9)
 Higher vocational education or university 914 (29.6) 63 (31.3) 851 (29.5)
BMI (kg/m2) 27.2 [25.0−29.6] 27.5 (3.3) 27.1 [25.0−29.6]
Obesity (BMI >30 kg/m2) 672 (21.8) 40 (19.9) 632 (21.9)
Waist-to-hip ratio 0.94 [0.89−0.99] 0.94 (0.08) 0.94 [0.89−0.99]
Systolic blood pressure (mm Hg) 141 [127−156] 140 [127−154] 141 [127.8−156]
Diastolic blood pressure (mm Hg) 84 [77−91] 83 [76−90] 84 [77−91]
Hypertension (%) 2,180 (70.7) 141 (70.1) 2039 (70.7)
Antihypertensive drug use (%) 1,305 (42.3) 94 (46.8) 1,211 (42.0)
Total cholesterol (mmol/L) 5.2 [4.5−5.9] 5.2 (1.0) 5.2 [4.5−5.9]
High-density lipoprotein cholesterol (mmol/L) 1.3 [1.0−1.5] 1.3 [1.0−1.5] 1.3 [1.0−1.5]
Triglycerides (mmol/L) 1.3 [1.0−1.8] 1.4 [1.1−1.9] 1.3 [1.0−1.8]
Hypercholesterolemia (%) 1,457 (47.2) 97 (48.3) 1,360 (47.2)
Lipid-lowering medication use (%) 989 (32.1) 68 (33.8) 921 (31.9)
Fasting glucose levels (mmol/L) 5.5 [5.2−6.1] 5.5 [5.2−6.2] 5.5 [5.2−6.1]
Diabetes mellitus (%) 439 (14.2) 30 (14.9) 409 (14.2)
Smoking status (%)
 Former 1819 (59.0) 129 (64.2) 1,690 (58.6)
 Current 533 (17.3) 30 (14.9) 503 (17.4)
Pack-years of ever smokers 20.0 [8.0−36.8] 20.0 [8.2−34.9] 20.0 [8.0−37.0]
Alcohol consumption (gram/day) 8.6 [1.6−20.0] 6.4 [1.6−10.7] 8.6 [1.6−20.0]
Physical activity (MET hours/week) 34.8 [15.0−68.7] 37.3 [18.0−70.3] 34.5 [14.8−68.5]

Abbreviations: BMI = body mass index; MET = metabolic equivalent of task.

Note: Imputed and unadjusted values of the cohort, with and without stratification for the migraine diagnosis, are displayed as means (SD) or medians [interquartile range, Q3–Q1] or as numbers (percentage). Shapiro-Wilk normality test was used to assess normality.